JP2014521313A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521313A5
JP2014521313A5 JP2014519454A JP2014519454A JP2014521313A5 JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5 JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014519454 A JP2014519454 A JP 2014519454A JP 2014521313 A5 JP2014521313 A5 JP 2014521313A5
Authority
JP
Japan
Prior art keywords
seq
antibody
antigen
cells
binding fragment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014519454A
Other languages
English (en)
Japanese (ja)
Other versions
JP6431370B2 (ja
JP2014521313A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/002945 external-priority patent/WO2013007388A1/en
Publication of JP2014521313A publication Critical patent/JP2014521313A/ja
Publication of JP2014521313A5 publication Critical patent/JP2014521313A5/ja
Application granted granted Critical
Publication of JP6431370B2 publication Critical patent/JP6431370B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014519454A 2011-07-13 2012-07-13 組換えDsbCを発現する細菌宿主系統 Active JP6431370B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11173880 2011-07-13
EP11173880.3 2011-07-13
PCT/EP2012/002945 WO2013007388A1 (en) 2011-07-13 2012-07-13 Bacterial host strain expressing recombinant dsbc

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017209932A Division JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統

Publications (3)

Publication Number Publication Date
JP2014521313A JP2014521313A (ja) 2014-08-28
JP2014521313A5 true JP2014521313A5 (https=) 2017-03-09
JP6431370B2 JP6431370B2 (ja) 2018-11-28

Family

ID=46545736

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014519454A Active JP6431370B2 (ja) 2011-07-13 2012-07-13 組換えDsbCを発現する細菌宿主系統
JP2017209932A Pending JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統
JP2019200029A Active JP7062626B2 (ja) 2011-07-13 2019-11-01 組換えDsbCを発現する細菌宿主系統

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017209932A Pending JP2018019719A (ja) 2011-07-13 2017-10-31 組換えDsbCを発現する細菌宿主系統
JP2019200029A Active JP7062626B2 (ja) 2011-07-13 2019-11-01 組換えDsbCを発現する細菌宿主系統

Country Status (27)

Country Link
US (2) US9725516B2 (https=)
EP (2) EP2731973B1 (https=)
JP (3) JP6431370B2 (https=)
KR (1) KR102023786B1 (https=)
CN (1) CN103649124B (https=)
AU (1) AU2012283388B2 (https=)
BR (1) BR112013032871B1 (https=)
CA (1) CA2841824C (https=)
CY (1) CY1119985T1 (https=)
DK (1) DK2731973T3 (https=)
EA (1) EA031449B1 (https=)
ES (1) ES2659155T3 (https=)
HR (1) HRP20180226T1 (https=)
HU (1) HUE035674T2 (https=)
IL (1) IL229947B (https=)
IN (1) IN2014DN00202A (https=)
LT (1) LT2731973T (https=)
ME (1) ME02957B (https=)
MX (1) MX348738B (https=)
NO (1) NO2731973T3 (https=)
PL (1) PL2731973T3 (https=)
PT (1) PT2731973T (https=)
RS (1) RS56926B1 (https=)
SG (1) SG10201807560XA (https=)
SI (1) SI2731973T1 (https=)
SM (1) SMT201800068T1 (https=)
WO (1) WO2013007388A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00832B (me) * 2007-03-22 2012-03-20 Ucb Biopharma Sprl Vezivni proteini uključujući antitjela, derivate antitjela i fragmente antitjela, koji specifično vezuju cd154 i njihova upotreba
US9109216B2 (en) 2009-09-24 2015-08-18 Ucb Pharma, S.A. Bacterial host strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000591D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
HRP20180226T1 (hr) * 2011-07-13 2018-03-09 Ucb Biopharma Sprl Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc
GB201208367D0 (en) * 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
GB201223276D0 (en) * 2012-12-21 2013-02-06 Ucb Pharma Sa Antibodies and methods of producing same
EP3237432B1 (en) 2014-12-22 2023-09-06 UCB Biopharma SRL Protein manufacture
KR101810778B1 (ko) * 2015-06-23 2017-12-20 서울대학교산학협력단 Cd154 결합 폴리펩타이드 및 그 용도
CN108495653A (zh) 2016-01-27 2018-09-04 免疫医疗有限责任公司 用于制备具有定义的糖基化模式抗体的方法
EP3774926A1 (en) 2018-04-05 2021-02-17 Bio-Rad ABD Serotec GmbH Display systems for proteins of interest
EP3877407B1 (en) * 2018-11-05 2026-03-11 F. Hoffmann-La Roche AG Methods of producing two chain proteins in prokaryotic host cells
CN109371049A (zh) * 2018-11-14 2019-02-22 天津大学 分子伴侣在促进单克隆抗体的形成和/或提高单克隆抗体的表达量中的应用
EP3942079A1 (en) 2019-03-18 2022-01-26 Bio-Rad ABD Serotec GmbH Protection of spytag-containing periplasmic fusion proteins from protease tsp and ompt degradation
DK4010500T3 (da) * 2019-08-05 2025-05-05 Wacker Chemie Ag Bakteriestamme til frigivelse af et rekombinant protein i en fermenteringsfremgangsmåde

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8907617D0 (en) 1989-04-05 1989-05-17 Celltech Ltd Drug delivery system
US5508192A (en) 1990-11-09 1996-04-16 Board Of Regents, The University Of Texas System Bacterial host strains for producing proteolytically sensitive polypeptides
US5264365A (en) 1990-11-09 1993-11-23 Board Of Regents, The University Of Texas System Protease-deficient bacterial strains for production of proteolytically sensitive polypeptides
GB9112536D0 (en) 1991-06-11 1991-07-31 Celltech Ltd Chemical compounds
US5474771A (en) 1991-11-15 1995-12-12 The Trustees Of Columbia University In The City Of New York Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of T-lymphocytes, compositions containing same
WO1993022331A1 (en) 1992-04-28 1993-11-11 The Regents Of The University Of Michigan Human crabp-i and crabp-ii
GB9215540D0 (en) 1992-07-22 1992-09-02 Celltech Ltd Protein expression system
US5304472A (en) 1992-11-20 1994-04-19 Genentech, Inc. Method of controlling polypeptide production in bacterial cells
US5639635A (en) 1994-11-03 1997-06-17 Genentech, Inc. Process for bacterial production of polypeptides
AU2660397A (en) 1996-04-05 1997-10-29 Board Of Regents, The University Of Texas System Methods for producing soluble, biologically-active disulfide bond-containing eukaryotic proteins in bacterial cells
GB9625640D0 (en) 1996-12-10 1997-01-29 Celltech Therapeutics Ltd Biological products
US6083715A (en) 1997-06-09 2000-07-04 Board Of Regents, The University Of Texas System Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells
JP2000083670A (ja) 1998-09-09 2000-03-28 Hsp Kenkyusho:Kk DsbA/DsbB/DsbC/DsbD発現プラスミド
DE60031533D1 (de) 1999-06-29 2006-12-07 Siga Technologies Inc Test für degp-protease inhibitoren
GB0006398D0 (en) 2000-03-16 2000-05-03 Novartis Ag Organic compounds
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
AU8867501A (en) 2000-09-01 2002-03-13 Biogen Inc Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design
WO2002018446A2 (en) 2000-09-01 2002-03-07 Biogen, Inc. Methods of designing and producing compounds having improved binding affinity for cd154 or other trimeric proteins
US7041479B2 (en) 2000-09-06 2006-05-09 The Board Of Trustess Of The Leland Stanford Junior University Enhanced in vitro synthesis of active proteins containing disulfide bonds
WO2002061090A2 (en) * 2000-12-14 2002-08-08 Genentech, Inc. Prokaryotically produced antibodies and uses thereof
JP4056880B2 (ja) 2000-12-14 2008-03-05 ジェネンテック・インコーポレーテッド 細菌性宿主株
TWI334439B (en) 2001-08-01 2010-12-11 Centocor Inc Anti-tnf antibodies, compositions, methods and uses
CN100513414C (zh) * 2001-08-27 2009-07-15 杰南技术公司 进行抗体表达和装配的系统
GB0124317D0 (en) 2001-10-10 2001-11-28 Celltech R&D Ltd Biological products
MXPA04004634A (es) 2001-11-16 2004-08-12 Idec Pharma Corp Expresion policistronica de anticuerpos.
GB0129105D0 (en) 2001-12-05 2002-01-23 Celltech R&D Ltd Expression control using variable intergenic sequences
AU2003244817B2 (en) 2002-06-28 2010-08-26 Domantis Limited Antigen-binding immunoglobulin single variable domains and dual-specific constructs
WO2004042017A2 (en) 2002-10-31 2004-05-21 Genentech, Inc. Methods and compositions for increasing antibody production
ES2374068T3 (es) 2002-12-03 2012-02-13 Ucb Pharma, S.A. Ensayo para identificar células productoras de anticuerpos.
GB0303337D0 (en) 2003-02-13 2003-03-19 Celltech R&D Ltd Biological products
EP1639014B1 (en) 2003-06-13 2010-09-22 Biogen Idec MA Inc. Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
DE602004017726D1 (de) 2003-06-30 2008-12-24 Domantis Ltd Pegylierte Single-domain-antikörper (dAb)
GB0315457D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
GB0315450D0 (en) 2003-07-01 2003-08-06 Celltech R&D Ltd Biological products
CA2533593A1 (en) 2003-07-26 2005-02-10 Biogen Idec Ma Inc. Altered antibodies having improved antigen-binding affinity
AU2005287406B2 (en) 2004-07-26 2011-08-18 Biogen Ma Inc. Anti-CD154 antibodies
WO2006028936A2 (en) * 2004-09-02 2006-03-16 Genentech, Inc. Heteromultimeric molecules
US7563443B2 (en) 2004-09-17 2009-07-21 Domantis Limited Monovalent anti-CD40L antibody polypeptides and compositions thereof
GB0425534D0 (en) 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
GB0520169D0 (en) 2005-10-04 2005-11-09 Celltech R&D Ltd Biological products
ME00832B (me) 2007-03-22 2012-03-20 Ucb Biopharma Sprl Vezivni proteini uključujući antitjela, derivate antitjela i fragmente antitjela, koji specifično vezuju cd154 i njihova upotreba
EP2535349A1 (en) 2007-09-26 2012-12-19 UCB Pharma S.A. Dual specificity antibody fusions
US7662587B1 (en) 2009-03-05 2010-02-16 E. I. Du Pont De Nemours And Company Gene knockout mutations that increase peptide production
US9109216B2 (en) 2009-09-24 2015-08-18 Ucb Pharma, S.A. Bacterial host strain
US8470552B2 (en) 2009-10-12 2013-06-25 Keck Graduate Institute Strategy to reduce lactic acid production and control PH in animal cell culture
EP2496601B1 (en) 2009-11-05 2017-06-07 F. Hoffmann-La Roche AG Methods and composition for secretion of heterologous polypeptides
GB201000591D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000588D0 (en) * 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201000587D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial hoist strain
GB201000590D0 (en) 2010-01-14 2010-03-03 Ucb Pharma Sa Bacterial host strain
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201012599D0 (en) 2010-07-27 2010-09-08 Ucb Pharma Sa Process for purifying proteins
HRP20180226T1 (hr) 2011-07-13 2018-03-09 Ucb Biopharma Sprl Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc
EP2546267A1 (en) 2011-07-13 2013-01-16 UCB Pharma S.A. Bacterial host strain expressing recombinant DsbC
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product

Similar Documents

Publication Publication Date Title
JP2014521313A5 (https=)
Silva et al. Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses
JP2021020905A5 (https=)
HRP20180226T1 (hr) Bakterijski soj domaćina koji eksprimira rekombinantnu dsbc
JP2018502572A5 (https=)
JP5731956B2 (ja) 可溶性ポリペプチドの単離方法
JP2005120106A5 (https=)
KR101796689B1 (ko) 안정화된 면역글로불린가변도메인 선별방법 및 선별된 도메인의 응용
JP2010273685A5 (https=)
JP2007530435A5 (https=)
JP2018506298A (ja) アゴニスト性tnf受容体結合物質
JP2020500510A5 (https=)
JP2011526480A5 (https=)
TW202112827A (zh) 與集落刺激因子1受體(csf1r)結合之抗體類
AU2007254004A1 (en) Engineered antibody-stress protein fusions
JP2009535021A5 (https=)
JP2009511000A5 (https=)
KR20180077144A (ko) 신규 항체 라이브러리 제조방법 및 이로부터 제조된 라이브러리
WO2022061594A1 (zh) 新型冠状病毒(sars-cov-2)刺突蛋白结合分子及其应用
JP2012524524A5 (https=)
JP2011523849A5 (https=)
CN110964110A (zh) 抗EGFR人源化的单域抗体、Fc融合蛋白、重链Fab蛋白及其应用
CN106928364B (zh) 一种FAP纳米抗体Nb26
JP2010279373A5 (https=)
CN113677704B (zh) Psma抗体及其应用